Press Enter to search · ESC to close

Macro US Stocks

Amundi CIO says AI focus to shift by 2027, favors pharma and biotech

Amundi Group Chief Investment Officer Vincent Mortier said investors have been “overly fixated” on core AI companies, and that this focus will shift by 2027. The European asset manager now favors sectors using AI to drive productivity gains and business transformation, including pharmaceuticals, biotech and some industrial firms. Mortier said the core AI segment is in the early stages of repricing, calling the adjustment “normal” after its extraordinary rally.

Share

Related News

新云社 share card
Long-press image above → Save to Photos / Share
Pitch us Feedback